In agreement with our results, TQ significantly decreased the expression of DNMT1 and DNMT3A in the primary blast cells from AML patients, ML-1, Kasumi-1, and MV4-11 AML cells [22]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.